Latest On Kala Pharmaceuticals, Inc (KALA):
About Kala Pharmaceuticals, Inc (KALA):
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development programs comprise KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; SEGRM program, a novel class of compounds designed to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway; and surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.
General
- Name Kala Pharmaceuticals, Inc
- Symbol KALA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 188
- Fiscal Year EndDecember
- IPO Date2017-07-20
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.kalarx.com
Valuation
- Price/Sales (Trailing 12 Mt.) 65.78
- Price/Book (Most Recent Quarter) 4.92
- Enterprise Value Revenue 69.03
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.76
- Next Year EPS Estimate -$0.66
- Next Quarter EPS Estimate -$0.78
- Operating Margin -1497%
- Return on Assets -32%
- Return on Equity -161%
- Revenue 6.36 million
- Earnings Per Share -$2.87
- Revenue Per Share $0.12
- Gross Profit 4.19 million
- Quarterly Earnings Growth 89.7%
Highlights
- Market Capitalization 493.03 million
- EBITDA -84957000
- PE Ratio -2.46
- Analyst Target Price $21.33
- Book Value Per Share $1.70
Share Statistics
- Shares Outstanding 61.55 million
- Shares Float 39.38 million
- % Held by Insiders 101%
- % Held by Institutions 81.46%
- Shares Short 10.59 million
- Shares Short Prior Month 9.34 million
- Short Ratio 4.18
- Short % of Float 24%
- Short % of Shares Outstanding 17%
Technicals
- Beta 0.39
- 52 Week High $14.68
- 52 Week Low $6.07
- 50 Day Moving Average 8.22
- 200 Day Moving Average 7.82
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Kala Pharmaceuticals, Inc (KALA) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Kala Pharmaceuticals, Inc (KALA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$0.55 | -$0.45 | -22.44% |
2020-09-30 | 2020-11-05 | $N/A | -$0.50 | -$0.45 | -10.21% |
2020-06-30 | 2020-08-06 | $N/A | -$0.42 | -$0.38 | -11.41% |
2020-03-31 | 2020-05-07 | $N/A | -$0.54 | -$0.45 | -20% |
2019-12-31 | 2020-02-12 | $1.18 million | -$0.63 | -$0.62 | -1.19% |
2019-09-30 | 2019-11-07 | $N/A | -$0.68 | -$0.65 | -4.97% |
2019-06-30 | 2019-08-06 | $2.06 million | -$0.70 | -$0.74 | 5.6% |
2019-03-31 | 2019-05-09 | $1.39 million | -$0.75 | -$0.81 | 6.88% |
2018-12-31 | 2019-03-11 | $N/A | -$0.75 | -$0.53 | -39.99% |
2018-09-30 | 2018-11-08 | $N/A | -$0.63 | -$0.64 | 1.56% |
2018-06-30 | 2018-08-09 | $N/A | -$0.60 | -$0.49 | -21.63% |
2018-03-31 | 2018-05-10 | $N/A | -$0.46 | -$0.46 | 0.65% |
2017-12-31 | 2018-03-26 | $N/A | -$0.46 | -$0.38 | -21.12% |
2017-09-30 | 2017-11-07 | $N/A | -$0.56 | -$0.43 | -31.76% |
2017-06-30 | 2017-08-31 | $N/A | -$9.30 | -$2.81 | -230.67% |
Kala Pharmaceuticals, Inc (KALA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Kala Pharmaceuticals, Inc (KALA) Chart:
Kala Pharmaceuticals, Inc (KALA) News:
Below you will find a list of latest news for Kala Pharmaceuticals, Inc (KALA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Kala Pharmaceuticals, Inc (KALA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest KALA Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:35 PM EST | 100 | $0.3562 |
Jun 13, 2022 7:48 PM EST | 100 | $0.3575 |
Jun 13, 2022 7:50 PM EST | 200 | $0.3578 |
Jun 13, 2022 7:50 PM EST | 17 | $0.3578 |
Jun 13, 2022 7:50 PM EST | 295 | $0.3578 |
Kala Pharmaceuticals, Inc (KALA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078332/0001104659-20-078332-index.htm |
2018-08-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1479419/000000000018025276/0000000000-18-025276-index.htm |
2020-05-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1479419/000000000020004214/0000000000-20-004214-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000084608719000053/0000846087-19-000053-index.htm |
2018-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000090221918000490/0000902219-18-000490-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000090221919000317/0000902219-19-000317-index.htm |
2018-10-02 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/1479419/000104746918006543/0001047469-18-006543-index.htm |
2018-10-03 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/1479419/000104746918006555/0001047469-18-006555-index.htm |
2020-03-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1479419/000104746920001367/0001047469-20-001367-index.htm |
2020-03-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1479419/000104746920001398/0001047469-20-001398-index.htm |
2020-05-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1479419/000104746920002892/0001047469-20-002892-index.htm |
2018-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465918053380/0001104659-18-053380-index.htm |
2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465918060021/0001104659-18-060021-index.htm |
2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465918060023/0001104659-18-060023-index.htm |
2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465918060617/0001104659-18-060617-index.htm |
2018-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465918062242/0001104659-18-062242-index.htm |
2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919033349/0001104659-19-033349-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034520/0001104659-19-034520-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034521/0001104659-19-034521-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034522/0001104659-19-034522-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034523/0001104659-19-034523-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034524/0001104659-19-034524-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465919034526/0001104659-19-034526-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465919044885/0001104659-19-044885-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920003222/0001104659-20-003222-index.htm |
2020-02-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1479419/000110465920019389/0001104659-20-019389-index.htm |
2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920030426/0001104659-20-030426-index.htm |
2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920031555/0001104659-20-031555-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920032036/0001104659-20-032036-index.htm |
2020-03-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1479419/000110465920033242/0001104659-20-033242-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920033391/0001104659-20-033391-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920033392/0001104659-20-033392-index.htm |
2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920044480/0001104659-20-044480-index.htm |
2020-05-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1479419/000110465920062530/0001104659-20-062530-index.htm |
2020-06-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1479419/000110465920076852/0001104659-20-076852-index.htm |
2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000110465920077452/0001104659-20-077452-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078271/0001104659-20-078271-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078279/0001104659-20-078279-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078287/0001104659-20-078287-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078309/0001104659-20-078309-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078310/0001104659-20-078310-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078317/0001104659-20-078317-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078319/0001104659-20-078319-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078323/0001104659-20-078323-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078325/0001104659-20-078325-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078326/0001104659-20-078326-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078327/0001104659-20-078327-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078328/0001104659-20-078328-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078330/0001104659-20-078330-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078332/0001104659-20-078332-index.htm |
2018-10-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1479419/000114420418052764/0001144204-18-052764-index.htm |
2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000114420418052767/0001144204-18-052767-index.htm |
2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000114420418052768/0001144204-18-052768-index.htm |
2018-10-12 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1479419/000114420418053658/0001144204-18-053658-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000117266119000440/0001172661-19-000440-index.htm |
2018-04-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018005505/0001179110-18-005505-index.htm |
2018-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018005506/0001179110-18-005506-index.htm |
2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008522/0001179110-18-008522-index.htm |
2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008523/0001179110-18-008523-index.htm |
2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008525/0001179110-18-008525-index.htm |
2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008526/0001179110-18-008526-index.htm |
2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008527/0001179110-18-008527-index.htm |
2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008573/0001179110-18-008573-index.htm |
2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018008574/0001179110-18-008574-index.htm |
2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911018012105/0001179110-18-012105-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000455/0001179110-19-000455-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000457/0001179110-19-000457-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000459/0001179110-19-000459-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000460/0001179110-19-000460-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000461/0001179110-19-000461-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019000462/0001179110-19-000462-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019011016/0001179110-19-011016-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911019011017/0001179110-19-011017-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000154/0001179110-20-000154-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000156/0001179110-20-000156-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000157/0001179110-20-000157-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000158/0001179110-20-000158-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000160/0001179110-20-000160-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020000161/0001179110-20-000161-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020003675/0001179110-20-003675-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020003841/0001179110-20-003841-index.htm |
2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004335/0001179110-20-004335-index.htm |
2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004834/0001179110-20-004834-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007239/0001179110-20-007239-index.htm |
2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007674/0001179110-20-007674-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010706/0001179110-20-010706-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010707/0001179110-20-010707-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010708/0001179110-20-010708-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010709/0001179110-20-010709-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010710/0001179110-20-010710-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010711/0001179110-20-010711-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000119312519037954/0001193125-19-037954-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1479419/000119312520033356/0001193125-20-033356-index.htm |
2020-03-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1479419/000119312520082611/0001193125-20-082611-index.htm |
2018-04-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1479419/000155837018002697/0001558370-18-002697-index.htm |
2018-04-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1479419/000155837018002698/0001558370-18-002698-index.htm |
2018-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1479419/000155837018003249/0001558370-18-003249-index.htm |
2018-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1479419/000155837018003328/0001558370-18-003328-index.htm |
2018-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018004568/0001558370-18-004568-index.htm |
2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837018004674/0001558370-18-004674-index.htm |
2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018005283/0001558370-18-005283-index.htm |
2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018006825/0001558370-18-006825-index.htm |
2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837018006883/0001558370-18-006883-index.htm |
2018-08-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1479419/000155837018006917/0001558370-18-006917-index.htm |
2018-08-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007113/0001558370-18-007113-index.htm |
2018-08-20 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007159/0001558370-18-007159-index.htm |
2018-08-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007161/0001558370-18-007161-index.htm |
2018-08-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007195/0001558370-18-007195-index.htm |
2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007359/0001558370-18-007359-index.htm |
2018-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018007676/0001558370-18-007676-index.htm |
2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018008253/0001558370-18-008253-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018009002/0001558370-18-009002-index.htm |
2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837018009054/0001558370-18-009054-index.htm |
2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837018009767/0001558370-18-009767-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019000060/0001558370-19-000060-index.htm |
2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019001781/0001558370-19-001781-index.htm |
2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1479419/000155837019001825/0001558370-19-001825-index.htm |
2019-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1479419/000155837019001827/0001558370-19-001827-index.htm |
2019-04-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1479419/000155837019002956/0001558370-19-002956-index.htm |
2019-04-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1479419/000155837019002961/0001558370-19-002961-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019004563/0001558370-19-004563-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837019004703/0001558370-19-004703-index.htm |
2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019005587/0001558370-19-005587-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019007149/0001558370-19-007149-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837019007251/0001558370-19-007251-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837019010281/0001558370-19-010281-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837019010366/0001558370-19-010366-index.htm |
2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020000702/0001558370-20-000702-index.htm |
2020-02-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1479419/000155837020000733/0001558370-20-000733-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1479419/000155837020004558/0001558370-20-004558-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1479419/000155837020004560/0001558370-20-004560-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020005533/0001558370-20-005533-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837020005698/0001558370-20-005698-index.htm |
2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020006941/0001558370-20-006941-index.htm |
2020-06-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1479419/000155837020007408/0001558370-20-007408-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020009498/0001558370-20-009498-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837020009714/0001558370-20-009714-index.htm |
2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020011192/0001558370-20-011192-index.htm |
2020-10-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020011765/0001558370-20-011765-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1479419/000155837020012691/0001558370-20-012691-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1479419/000155837020012835/0001558370-20-012835-index.htm |
2018-08-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1479419/999999999518002212/9999999995-18-002212-index.htm |
2020-05-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1479419/999999999520001204/9999999995-20-001204-index.htm |
2018-04-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1479419/999999999718004980/9999999997-18-004980-index.htm |
2018-08-22 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1479419/999999999718007412/9999999997-18-007412-index.htm |
2018-10-09 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1479419/999999999718008524/9999999997-18-008524-index.htm |
2020-05-01 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1479419/999999999720002358/9999999997-20-002358-index.htm |
Kala Pharmaceuticals, Inc (KALA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kala Pharmaceuticals, Inc (KALA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 101%Institutional Ownership: 8146%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-03-16 | Todd Bazemore | Chief Operating Officer | Buy | 10,000.00 | 5.75 | 57,500.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020003841/0001179110-20-003841-index.htm |
2020-06-25 | Hongming Chen | Chief Scientific Officer | Buy | 16,000.00 | 102,849.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078279/0001104659-20-078279-index.htm | ||
2020-10-26 | Eric Trachtenberg | Officer | Buy | 61,000.00 | 105,901.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010710/0001179110-20-010710-index.htm | ||
2020-03-13 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 6,337,135.00 | 7.89 | 49,999,995.15 | 10,874,613.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920033391/0001104659-20-033391-index.htm |
2020-03-13 | Rajeev M. Shah | Director | Buy | 6,337,135.00 | 7.89 | 49,999,995.15 | 10,874,613.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920033392/0001104659-20-033392-index.htm |
2020-10-26 | Todd Bazemore | Chief Operating Officer | Buy | 81,000.00 | 110,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010711/0001179110-20-010711-index.htm | ||
2020-04-09 | Romulus K Brazzell | Chief Medical Officer | Buy | 1,880.00 | 0.68 | 1,278.40 | 110,605.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004834/0001179110-20-004834-index.htm |
2020-10-26 | Mary Reumuth | Chief Financial Officer | Buy | 61,000.00 | 125,293.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010706/0001179110-20-010706-index.htm | ||
2020-04-09 | Romulus K Brazzell | Chief Medical Officer | Buy | 18,247.00 | 2.30 | 41,968.10 | 128,852.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004834/0001179110-20-004834-index.htm |
2020-06-09 | Mary Reumuth | Chief Financial Officer | Buy | 11,520.00 | 2.30 | 26,496.00 | 16,336.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007239/0001179110-20-007239-index.htm |
2020-10-26 | Hongming Chen | Chief Scientific Officer | Buy | 61,000.00 | 163,849.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010709/0001179110-20-010709-index.htm | ||
2020-04-09 | Romulus K Brazzell | Chief Medical Officer | Buy | 47,644.00 | 3.34 | 159,130.96 | 176,496.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004834/0001179110-20-004834-index.htm |
2020-06-25 | Romulus K Brazzell | Chief Medical Officer | Buy | 19,000.00 | 195,496.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078309/0001104659-20-078309-index.htm | ||
2020-06-25 | GREGORY D PERRY | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078327/0001104659-20-078327-index.htm | ||
2020-06-25 | Gregory Grunberg | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078310/0001104659-20-078310-index.htm | ||
2020-06-25 | Rajeev M. Shah | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078330/0001104659-20-078330-index.htm | ||
2020-06-25 | Robert Bradley Paull | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078319/0001104659-20-078319-index.htm | ||
2020-06-09 | Mary Reumuth | Chief Financial Officer | Buy | 5,077.00 | 5.21 | 26,451.17 | 21,413.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007239/0001179110-20-007239-index.htm |
2020-10-26 | Mark T Iwicki | Chief Executive Officer | Buy | 178,300.00 | 227,860.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010707/0001179110-20-010707-index.htm | ||
2020-06-25 | Howard B Rosen | Director | Buy | 20,000.00 | 24,824.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078326/0001104659-20-078326-index.htm | ||
2020-03-13 | Gregory Grunberg | Director | Buy | 2,534,854.00 | 7.89 | 19,999,998.06 | 2,534,854.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020003675/0001179110-20-003675-index.htm |
2020-10-26 | Romulus K Brazzell | Chief Medical Officer | Buy | 81,000.00 | 276,496.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010708/0001179110-20-010708-index.htm | ||
2020-06-25 | ANDREW I KOVEN | Director | Buy | 28,000.00 | 28,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078287/0001104659-20-078287-index.htm | ||
2018-10-05 | Gregory Grunberg | Director | Buy | 606,060.00 | 8.25 | 4,999,995.00 | 2,877,006.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911018012105/0001179110-18-012105-index.htm |
2019-08-19 | Howard B Rosen | Director | Buy | 2,880.00 | 0.68 | 1,958.40 | 2,880.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078325/0001104659-20-078325-index.htm |
2020-06-19 | Eric Trachtenberg | Officer | Buy | 28,901.00 | 5.19 | 149,996.19 | 28,901.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007674/0001179110-20-007674-index.htm |
2020-06-25 | Todd Bazemore | Chief Operating Officer | Buy | 19,000.00 | 29,000.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078271/0001104659-20-078271-index.htm | ||
2020-06-09 | Mary Reumuth | Chief Financial Officer | Buy | 15,360.00 | 2.30 | 35,328.00 | 36,773.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007239/0001179110-20-007239-index.htm |
2020-10-22 | Todd Bazemore | Chief Operating Officer | Buy | 40.00 | 7.60 | 304.00 | 42.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020010711/0001179110-20-010711-index.htm |
2020-06-25 | Eric Trachtenberg | Officer | Buy | 16,000.00 | 44,901.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078332/0001104659-20-078332-index.htm | ||
2018-10-03 | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 2,424,242.00 | 8.25 | 19,999,996.50 | 4,537,478.00 | https://www.sec.gov/Archives/edgar/data/1479419/000114420418052767/0001144204-18-052767-index.htm |
2018-10-03 | Rajeev M. Shah | Director | Buy | 2,424,242.00 | 8.25 | 19,999,996.50 | 4,537,478.00 | https://www.sec.gov/Archives/edgar/data/1479419/000114420418052768/0001144204-18-052768-index.htm |
2019-08-19 | Howard B Rosen | Director | Buy | 1,944.00 | 0.47 | 913.68 | 4,824.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078325/0001104659-20-078325-index.htm |
2020-06-09 | Mary Reumuth | Chief Financial Officer | Buy | 11,520.00 | 2.30 | 26,496.00 | 48,293.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020007239/0001179110-20-007239-index.htm |
2020-06-25 | Mark T Iwicki | Chief Executive Officer | Buy | 49,560.00 | 49,560.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078323/0001104659-20-078323-index.htm | ||
2020-06-25 | Mary Reumuth | Chief Financial Officer | Buy | 16,000.00 | 64,293.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465920078328/0001104659-20-078328-index.htm | ||
2019-05-30 | Howard B Rosen | Director | Buy | 5,000.00 | 5.42 | 27,100.00 | 8,240.00 | https://www.sec.gov/Archives/edgar/data/1479419/000110465919033349/0001104659-19-033349-index.htm |
2020-03-30 | Hongming Chen | Chief Scientific Officer | Buy | 31,000.00 | 2.30 | 71,300.00 | 86,849.00 | https://www.sec.gov/Archives/edgar/data/1479419/000117911020004335/0001179110-20-004335-index.htm |